✦ LIBER ✦

P41 Urokinase plasminogen activator and cathepsin D in micrometastatic cells of patients with primary breast cancer

✍ Scribed by E.-F. Solomayer; I.J. Diel; Ch. Gollan; G. Meyberg; S. Bode; D. Wallwiener; G. Bastert

Book ID: 117665478
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 310 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)89259-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cellular localisation byin situhybridisa

Cellular localisation byin situhybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer

✍ Chantal Escot; Yong Zhao; Carole Puech; Henri Rochefort 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 891 KB

Physiological and pathological changes o

Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients

✍ Hyun Cheol Chung; Sun Young Rha; Joon Oh Park; Nae Choon Yoo; Joo Hang Kim; Jae 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 670 KB

Real-time quantitative PCR determination

Real-time quantitative PCR determination of urokinase-type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients

✍ Jean-Yves Pierga; Charlyne Bonneton; Henri Magdelénat; Anne Vincent-Salomon; Cla 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 294 KB 👁 1 views

## Abstract Disseminated tumor cells (DTC) in bone marrow are independently related to poor outcome in patients with breast cancer. Phenotypic characterization of DTC may be useful to improve evaluation of the metastasizing potential of DTC and also to more accurately target aggressive tumor cells.

Urokinase plasminogen activator as a pro

Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer

✍ Michael J. Duffy; David Reilly; E. McDermott; Niall O'Higgins; James J. Fennelly 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB 👁 2 views

Cathepsin-D, urokinase plasminogen activ

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors

✍ Jahkola, T; Toivonen, T; Smitten, K von; Virtanen, I; Wasenius, V-M; Blomqvist, 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 284 KB

The prognostic value of plasminogen-acti

The prognostic value of plasminogen-activator inhibitor-1 (PAI-1) and the metastasis-associated proteases urokinase (uPA) and cathepsin-D in primary breast cancer: A multivariate analysis in 657 patients

✍ Klijn, JGM; Schmitt, M; Van Putten, WLJ; Jänicke, F; Foekens, JA 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 168 KB